Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02026752 · ClinicalTrials.gov registry record
Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay
A clinical trial, sponsored by Gen-Probe, Incorporated.
- Completed
- Registry status
- 468
- Enrollment target
NCT02026752 is a clinical trial that has completed, run by Gen-Probe, Incorporated. The registered enrollment target is 468 participants.
The verdict
NCT02026752 has completed, sponsored by Gen-Probe, Incorporated.
- COMPLETED
- Registry status
- 468 participants
- Enrollment target
Study Summary
The objective is to obtain plasma samples from Human Immunodeficiency Virus Type 1 (HIV-1) infected individuals that have viral loads across the dynamic range of the Aptima HIV-1 assay. The plasma samples will be tested in a method comparison study to support the approval of the Aptima HIV-1 assay on Gen-Probe's Panther testing system. The objective of the method comparison study is to evaluate the clinical utility of the Aptima HIV-1 assay by comparing the results to the FDA-licensed COBAS assay (Roche Molecular Systems, Inc., Branchburg, New Jersey) in plasma samples that have viral loads across the dynamic range of the Aptima HIV-1 assay.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 468 participants |
| Start Date | 2014-01 |
| Est. Completion | 2017-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02026752
The ClinicalTrials.gov registry entry for NCT02026752 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 468 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gen-Probe, Incorporated, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02026752 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02026752 about?
NCT02026752 is a clinical study titled "Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay". The objective is to obtain plasma samples from Human Immunodeficiency Virus Type 1 (HIV-1) infected individuals that have viral loads across the dynamic range of the Aptima HIV-1 assay. The plasma samples will be tested in a method comparison study to support the approval of the Aptima HIV-1 assay o...
What is the current status of trial NCT02026752?
This trial is currently completed. The enrollment target is 468 participants. The study started on 2014-01. Estimated completion is 2017-01.
Who is sponsoring clinical trial NCT02026752?
This trial is sponsored by Gen-Probe, Incorporated, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.